Company: JUNS
Filing Date: 2025-11-06
Form Type: DEF 14A
Source: 0001493152-25-020988
Chunk: 8

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-06
Form: DEF 14A
Chunk 8
---
 come before the virtual Annual Meeting. As of the Record Date, the Company has no voting shares other than the Common Stock. The Commitment Shares may not be voted in favor of Proposal 5.

What is the difference between holding shares as a record holder and as a beneficial owner (holding shares in street name)?

If your shares are registered in your name with our transfer agent, Equiniti Trust Company, LLC, you are the “ record holder” of those shares. If you are a record holder, these proxy materials have been provided directly to you by the Company.

If your shares are held in a stock brokerage account, a bank or other holder of record, you are considered the “ beneficial owner” of those shares held in “ street name.” If your shares are held in street name, these proxy materials have been forwarded to you by that organization. The organization holding your account is considered to be the stockholder of record for purposes of voting at the virtual Annual Meeting. As the beneficial owner, you have the right to instruct this organization on how to vote your shares.

| -3- |

Who may attend the virtual Annual Meeting?

Only record holders and beneficial owners of our Common Stock, or their duly authorized proxies, may attend the virtual Annual Meeting.

What am I voting for at the virtual Annual Meeting?

Stockholders will vote on the following items at thevirtual Annual Meeting:

1. To elect seven (7) directors, the names of whom are set forth in the accompanying Proxy Statement, each to serve until the 2026 annual meeting of stockholders and until their respective successors are duly elected and qualified;

2. To approve an amendment to the Company’s certificate of incorporation to increase the authorized shares of Common Stock available for issuance from 125,000,000 shares to 500,000,000 shares;

3. To adopt the Jupiter Neurosciences, Inc. 2025 Equity Incentive Plan;

4. To ratify the selection of Cherry Bekaert as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025;

5. To approve, for purposes of complying with Nasdaq Listing Rules 5635(b) and 5635(d), the potential issuance of shares of Common Stock, in excess of 19.99% or more of the Company’s issued and outstanding Common Stock of up to $20 million of securities pursuant to the SEPA with Yorkville, including upon conversion of convertible promissory notes issued to Yorkville in connection with the SEPA; and